Simultaneous polysubstance use among Danish 3,4-methylenedioxymethamphetamine and hallucinogen users: combination patterns and proposed biological bases.
Licht CL, Christoffersen M, Okholm M, Damgaard L, Fink-Jensen A, Knudsen GM, Erritzoe D
Publication record · Explore literaturePublic tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.
References — this paper cites (0)
No references identified in the available metadata. This does not establish that none exist.
Cited by — these papers cite this paper (4)
- Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical Development 2026-07-03 · Expand citations
- Prevalence and Correlates of Past-Year Psilocybin Use in the U.S., 2024, USA 2026-05-01 · Expand citations
- Interactions between psilocybin, LSD, and serotonergic antidepressants: A qualitative analysis of user reports 2025-11-20 · Expand citations
- Psychedelic experience dose-dependently modulated by cannabis: results of a prospective online survey 2021-11-03 · Expand citations